相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of outcome of patients with acute minor ischaemic stroke treated with intravenous t-PA, DAPT or aspirin
Peng Wang et al.
STROKE AND VASCULAR NEUROLOGY (2021)
Thrombolysis in Mild Stroke A Comparative Analysis of the PRISMS and MaRISS Studies
Negar Asdaghi et al.
STROKE (2021)
Low-dose versus standard-dose alteplase in acute ischemic stroke in Asian stroke registries: an individual patient data pooling study
Xia Wang et al.
INTERNATIONAL JOURNAL OF STROKE (2019)
Reperfusion therapy for minor stroke: A systematic review and meta-analysis
Lihuan Lan et al.
BRAIN AND BEHAVIOR (2019)
Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
William J. Powers et al.
STROKE (2019)
Intravenous Alteplase for Mild Nondisabling Acute Ischemic Stroke A Bridge Too Far?
William J. Powers
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits The PRISMS Randomized Clinical Trial
Pooja Khatri et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis
Shoujiang You et al.
STROKE AND VASCULAR NEUROLOGY (2018)
Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke
C. S. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes A Pooled Analysis of 9 Trials
Kennedy R. Lees et al.
STROKE (2016)
Defining Minor Symptoms in Acute Ischemic Stroke
Davide Strambo et al.
CEREBROVASCULAR DISEASES (2015)
Thrombolysis for Acute Minor Stroke: Outcome and Barriers to Management
Chloe Laurencin et al.
CEREBROVASCULAR DISEASES (2015)
Defining Mild Stroke: Outcomes Analysis of Treated and Untreated Mild Stroke Patients
Ilana Spokoyny et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2015)
Effect of Intravenous Recombinant Tissue-Type Plasminogen Activator in Patients With Mild Stroke in the Third International Stroke Trial-3 Post Hoc Analysis
Pooja Khatri et al.
STROKE (2015)
Comparative Effectiveness of Standard Care With IV Thrombolysis Versus Without IV Thrombolysis for Mild Ischemic Stroke
Jay Chol Choi et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Defining Mild Stroke: Outcomes Analysis of Treated and Untreated Mild Stroke Patients
Ilana Spokoyny et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2015)
Outcomes in Mild Acute Ischemic Stroke Treated With Intravenous Thrombolysis A Retrospective Analysis of the Get With the Guidelines-Stroke Registry
Jose G. Romano et al.
JAMA NEUROLOGY (2015)
Intravenously Administered Tissue Plasminogen Activator Useful in Milder Strokes? A Meta-analysis
Leonard L. L. Yeo et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2014)
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
Jonathan Emberson et al.
LANCET (2014)
Safety and Outcome of Thrombolysis in Mild Stroke: A Meta-Analysis
Yuming Xu
MEDICAL SCIENCE MONITOR (2014)
The challenges of determining noninferiority margins: a case study of noninferiority randomized controlled trials of novel oral anticoagulants
Grace Wangge et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2013)
Review, Historical Context, and Clarifications of the NINDS rt-PA Stroke Trials Exclusion Criteria Part 1: Rapidly Improving Stroke Symptoms
Steven R. Levine et al.
STROKE (2013)
Thrombolysis in Stroke Despite Contraindications or Warnings?
Benedikt Frank et al.
STROKE (2013)
Early Neurological Deterioration within 24 Hours after Intravenous rt-PA Therapy for Stroke Patients: The Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry
Mayumi Mori et al.
CEREBROVASCULAR DISEASES (2012)
Intravenous Tissue Plasminogen Activator for Patients with Minor Ischemic Stroke
Branko N. Huisa et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2012)
Statistical Analysis of the Primary Outcome in Acute Stroke Trials
Philip M. W. Bath et al.
STROKE (2012)
Ninety-Day Outcome Rates of a Prospective Cohort of Consecutive Patients With Mild Ischemic Stroke
Pooja Khatri et al.
STROKE (2012)
Zero on the NIHSS Does Not Equal the Absence of Stroke
Sheryl Martin-Schild et al.
ANNALS OF EMERGENCY MEDICINE (2011)
Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR
Niaz Ahmed et al.
LANCET NEUROLOGY (2010)
Very Mild Stroke Patients Benefit from Intravenous Tissue Plasminogen Activator Without Increase of Intracranial Hemorrhage
Ameer E. Hassan et al.
SOUTHERN MEDICAL JOURNAL (2010)
Strokes With Minor Symptoms An Exploratory Analysis of the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Trials
Pooja Khatri et al.
STROKE (2010)
Effects of 0.6 mg/kg Intravenous Alteplase on Vascular and Clinical Outcomes in Middle Cerebral Artery Occlusion Japan Alteplase Clinical Trial II (J-ACT II)
Etsuro Mori et al.
STROKE (2010)
Safety and Outcome after Thrombolysis in Stroke Patients with Mild Symptoms
M. Koehrmann et al.
CEREBROVASCULAR DISEASES (2009)
Registries and Selection Bias The Need for Accountability
Harlan M. Krumholz
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2009)
Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaernic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial
Erich Bluhmki et al.
LANCET NEUROLOGY (2009)
Long-Term Functional Recovery After First Ischemic Stroke The Northern Manhattan Study
Mandip S. Dhamoon et al.
STROKE (2009)
Early MRI and outcomes of untreated patients with mild or improving ischemic stroke
V. Rajajee et al.
NEUROLOGY (2006)
Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset - Japan Alteplase Clinical Trial (J-ACT)
Takenori Yamaguchi et al.
STROKE (2006)
Recombinant tissue plasminogen activator for minor strokes: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Experience
JP Broderick et al.
ANNALS OF EMERGENCY MEDICINE (2005)
Enhancing the development and approval of acute stroke therapies - Stroke Therapy Academic Industry Roundtable
M Fisher
STROKE (2005)
Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial
TJ Ingall et al.
STROKE (2004)
分享论文
